Xu J - Search Results

1

Profiling the selected hotspots for ear traits in two maize-teosinte populations.

Feng X, Guan H, Wen Y, Zhou H, Xing X, Li Y, Zheng D, Wang Q, Zhang W, Xiong H, Hu Y, Jia L, Luo S, Zhang X, Guo W, Wu F, Xu J, Liu Y, Lu Y. Feng X, et al. Among authors: xu j. Theor Appl Genet. 2024 Mar 7;137(3):74. doi: 10.1007/s00122-024-04554-8. Theor Appl Genet. 2024. PMID: 38451289

2

Identification and Functional Analysis of Drought-Responsive Long Noncoding RNAs in Maize Roots.

Tang X, Li Q, Feng X, Yang B, Zhong X, Zhou Y, Wang Q, Mao Y, Xie W, Liu T, Tang Q, Guo W, Wu F, Feng X, Wang Q, Lu Y, Xu J. Tang X, et al. Among authors: xu j. Int J Mol Sci. 2023 Oct 10;24(20):15039. doi: 10.3390/ijms242015039. Int J Mol Sci. 2023. PMID: 37894720 Free PMC article.

3

Two all-biomass cellulose/amino acid spherical nanoadsorbents based on a tri-aldehyde spherical nanocellulose II amino acid premodification platform for the efficient removal of Cr(VI) and Cu(II).

Zhang S, Zhu G, Xu X, Luo F, Tian D, Liu Y, Wang Q, Chen Q, Jiang Y, Qi J, Xu J, Wu F, Feng X, Tang Q, Guo W, Lu Y. Zhang S, et al. Among authors: xu x, xu j. Int J Biol Macromol. 2024 Feb;258(Pt 1):128748. doi: 10.1016/j.ijbiomac.2023.128748. Epub 2023 Dec 15. Int J Biol Macromol. 2024. PMID: 38104693

4

Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

Xu J, Guo W, Xie L. Xu J, et al. BMC Cancer. 2018 Oct 16;18(1):987. doi: 10.1186/s12885-018-4872-x. BMC Cancer. 2018. PMID: 30326879 Free PMC article.

5

Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?

Xu J, Xie L, Guo W. Xu J, et al. Clin Orthop Relat Res. 2018 Nov;476(11):2177-2186. doi: 10.1097/CORR.0000000000000387. Clin Orthop Relat Res. 2018. PMID: 29912746 Free PMC article.

6

PDGF/PDGFR effects in osteosarcoma and the "add-on" strategy.

Xu J, Xie L, Guo W. Xu J, et al. Clin Sarcoma Res. 2018 Aug 2;8:15. doi: 10.1186/s13569-018-0102-1. eCollection 2018. Clin Sarcoma Res. 2018. PMID: 30083310 Free PMC article. Review.

7

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs.

Chen C, Xie L, Ren T, Huang Y, Xu J, Guo W. Chen C, et al. Among authors: xu j. Cancer Lett. 2021 Mar 1;500:1-10. doi: 10.1016/j.canlet.2020.12.024. Epub 2020 Dec 23. Cancer Lett. 2021. PMID: 33359211 Review.

8

Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma.

Sun X, Xu J, Xie L, Guo W. Sun X, et al. Among authors: xu j. Int J Gen Med. 2022 Sep 28;15:7581-7591. doi: 10.2147/IJGM.S379269. eCollection 2022. Int J Gen Med. 2022. PMID: 36196372 Free PMC article.

9

Improving Bioavailability of Hydrophobic Prodrugs through Supramolecular Nanocarriers Based on Recombinant Proteins for Osteosarcoma Treatment.

Wang S, Li B, Zhang H, Chen J, Sun X, Xu J, Ren T, Zhang Y, Ma C, Guo W, Liu K. Wang S, et al. Among authors: xu j. Angew Chem Int Ed Engl. 2021 May 10;60(20):11252-11256. doi: 10.1002/anie.202101938. Epub 2021 Apr 8. Angew Chem Int Ed Engl. 2021. PMID: 33650286

10

Mesenchymal chondrosarcoma of bone and soft tissue: a systematic review of 107 patients in the past 20 years.

Xu J, Li D, Xie L, Tang S, Guo W. Xu J, et al. PLoS One. 2015 Apr 7;10(4):e0122216. doi: 10.1371/journal.pone.0122216. eCollection 2015. PLoS One. 2015. PMID: 25849226 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,371 results

Search Page

Filters